Subject Matter Expert Opinion

3.24.2014 Market Access

Patient-Reported Outcomes Spurred by Big Data in Pharma

By Nicole May, Research Analyst The opportunities are countless for Big Data in pharma, particularly within the clinical trial space.  Harnessing the data generated during clinical trials could help shorten trial timelines and lead to less expensive...
 

3.18.2014 Marketing

Want to Optimize Your Pharmaceutical Digital Marketing Strategies? Build the Right Team…

By Christie Shilling, Research Analyst Digital marketing is not the new kid on the block — not even in pharma.  It hasn’t been for a while.  But many companies still lag behind when it comes to understanding the tools required for it and how...
 

3.17.2014 Sales

Tracking Key Accounts: Implementing CRMs for Effective Pharmaceutical Sales Management

By Victoria Cavicchi, Research Analyst Since the early 2000s, the life sciences industry has been shifting toward leaner sales forces.  As commercial field teams shrink and more physicians are closing their doors to sales reps, companies look toward...
 

2.26.2014 Account Strategy for Payer Organizations

Provide a Framework for New Product Planning Groups to Influence Clinical Trials

By Jacob Presson, Research Analyst A common theme running through a lot of what we at Cutting Edge Information learn while conducting research on the pharmaceutical industry is the need for more consistent and productive communication between internal...
 

2.19.2014 Medical Affairs

Advisory Boards Put the Marketplace in Your Conference Room

By Jacob Presson, Research Analyst This blog has previously discussed in detail how pharmaceutical companies are turning to advisory boards to inform their clinical trial strategies and increasingly to provide assistance when conferring with payers...
 

1.31.2014 Quality Control and Assurance

Pharma Companies Increase Cross-Functional Communication with Regulatory Affairs Teams

By Yanis Saradjian, Director of Consulting The last 10 years have seen regulatory affairs groups evolve from a group focused on submitting new drug applications and coordinating communication with regulatory agencies.   Regulatory groups now expect...
 

1.22.2014 Regulatory Affairs

The Regulatory Hokey Pokey

By Jacob Presson, Research Analyst Many readers will be familiar with the children’s dance song “The Hokey Pokey” (or “Hokey Cokey” for our UK-based readership) which instructs participants to, “put your right arm in, put your right...
 

12.23.2013 Medical Affairs

Putting the “Access” in “Open Access”: How Pharma Can Harness the Power of Online Journals

By Christie Shilling, Research Analyst With the expansion of digital communication technologies, pharma is one among many industries trying to optimize its strategies using these new tools.  Marketing and sales in particular have begun to find...
 

12.23.2013 Marketing

Want Successful Promotional Speaker Events? Recruit Presenters With These Traits

By Jennifer Harrell, Research Analyst Facing increased regulatory scrutiny and poor public perception, pharmaceutical companies do not want to host promotional speaker programs in vain. So how can a company really drive home its point? Sir...
 

12.23.2013 Marketing

Customize an Online Community to Take Control of Social Media

By Natalie DeMasi, Research Analyst Social media is one of the hottest spots for pharma marketing these days, but many companies confine themselves to YouTube, Twitter and Facebook.  Sixty-two percent of surveyed companies use Facebook for marketing,...